Glucagon-like peptide-1 (GLP-1) receptor agonists may help lower the risk of developing cirrhosis and liver cancer in patients with type 2 diabetes and chronic liver disease, a new study indicates
Medical history, current medications, and individual weight loss goals are carefully reviewed to determine whether GLP-1 treatment is appropriate
Understanding how peptides interact with cellular signaling provides important context for why pathway-specific interventions like PTD-DBM represent a fundamentally different approach than conventional treatments
Prior to initiating saxagliptin, vildagliptin or alogliptin: Check liver and kidney function During treatment: Vildagliptin: Monitor liver function tests (LFTs) at 3-monthly intervals post-initiation for the first year and periodically thereafter
Results showed that follicles treated with moderate concentrations (0.5 and 5 M) exhibited a significant stimulation of hair shaft elongation , with a 37% increase in hair length compared to the control group
Glycerin (90mg) Helps maintain hydration balance